article thumbnail

CBD and Depression: Can It Really Help?

PrestoDoctor

If you’ve been thinking about using CBD for your depression, there may be no better time than now if you want to move forward and learn more about how the medical process works. Telemedicine in the states listed above allows you to receive an online customized treatment plan after a confidential medical evaluation with a physician.

CBD
article thumbnail

Document: Barr Responses To QFR’s: CLR Digs Out The Relevant Q’s & A’s

Cannabis Law Report

The Food and Drug Administration (FDA) recently approved Epidiolex, whose main active ingredient is CBD. Senator Feinstein and I wrote to DOJ and Health and Human Services (HHS) on two occasions requesting that a scientific and medical evaluation of CBD be conducted.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Three Myths and Three Facts on the HUGE Marijuana Rescheduling Recommendation

Canna Law Blog

This means that the country’s top health agency has finally conceded that cannabis has medical value, and isn’t a drug of abuse on par with fentanyl or heroin. As an HHS spokesperson explained: “While HHS’s scientific and medical evaluation is binding on DEA, the scheduling recommendation is not.

DEA
article thumbnail

Further Consideration of the STATES Act

Cannabis Law Report

The Attorney General forwards the request to the Health and Human Services Secretary and requests a scientific and medical evaluation and recommendation, as specified by 23 USC 811(b-c). HHS, through the Food and Drug Administration, conducts an assessment and returns a recommendation to the Attorney General “in a timely manner.”.

article thumbnail

DEA Pushes Marijuana Rescheduling Hearing To December: What Does This Mean For Cannabis?

Veriheal

This recommendation resulted from a thorough scientific and medical evaluation of cannabis by HHS, which determined that cannabis does have “currently accepted medical use” in the U.S. In August 2023, the HHS also crucially recommended to the DEA that cannabis be relisted from Schedule I to Schedule III.

DEA